Literature DB >> 22618987

Living-donor lobar lung transplantation for rapidly progressive interstitial pneumonia associated with clinically amyopathic dermatomyositis: report of a case.

Tsuyoshi Shoji1, Toru Bando, Takuji Fujinaga, Fengshi Chen, Hajime Sasano, Naoichiro Yukawa, Tsuneyo Mimori, Hiroshi Date.   

Abstract

Diffuse interstitial pneumonia (IP) associated with collagen disease is a rare indication for lung transplantation. The manifestations of collagen disease are variable and dermatomyositis (DM) is often considered a contraindication for lung transplantation because of active myositis and a high incidence of malignancy. Furthermore, clinically amyopathic dermatomyositis (C-ADM) is associated with rapidly progressive IP resulting in a poor prognosis. Bilateral living-donor lobar lung was transplanted in a 52-year-old female with rapidly progressive IP associated with C-ADM, and the postoperative course was uneventful. To our knowledge, this case represents the first living-donor lobar lung transplantation for a patient with rapidly progressive IP associated with C-ADM.

Entities:  

Mesh:

Year:  2012        PMID: 22618987     DOI: 10.1007/s11748-012-0106-3

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN: 1863-6705


  9 in total

1.  Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis siné myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness?

Authors:  Richard D Sontheimer
Journal:  J Am Acad Dermatol       Date:  2002-04       Impact factor: 11.527

2.  International guidelines for the selection of lung transplant candidates: 2006 update--a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation.

Authors:  Jonathan B Orens; Marc Estenne; Selim Arcasoy; John V Conte; Paul Corris; Jim J Egan; Thomas Egan; Shaf Keshavjee; Christiane Knoop; Robert Kotloff; Fernando J Martinez; Steven Nathan; Scott Palmer; Alec Patterson; Lianne Singer; Gregory Snell; Sean Studer; J L Vachiery; Allan R Glanville
Journal:  J Heart Lung Transplant       Date:  2006-07       Impact factor: 10.247

3.  Successful lung transplantation in a patient with dermatomyositis and acute form of interstitial pneumonitis.

Authors:  J Kim; Y W Kim; S M Lee; Y S Kim; Y T Kim; Y W Song
Journal:  Clin Exp Rheumatol       Date:  2009 Jan-Feb       Impact factor: 4.473

4.  Living-donor lobar lung transplantation for interstitial pneumonia associated with dermatomyositis.

Authors:  Tsuyoshi Shoji; Toru Bando; Takuji Fujinaga; Kenichi Okubo; Naoichiro Yukawa; Tsuneyo Mimori; Hiroshi Date
Journal:  Transpl Int       Date:  2010-03-04       Impact factor: 3.782

5.  Polymyositis/dermatomyositis-associated lung disease: analysis of a series of 81 patients.

Authors:  A Selva-O'Callaghan; M Labrador-Horrillo; X Muñoz-Gall; X Martínez-Gomez; J Majó-Masferrer; R Solans-Laque; C P Simeon-Aznar; F Morell-Brotard; M Vilardell-Tarrés
Journal:  Lupus       Date:  2005       Impact factor: 2.911

6.  Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis.

Authors:  Shinji Sato; Michito Hirakata; Masataka Kuwana; Akira Suwa; Shinichi Inada; Tsuneyo Mimori; Takeji Nishikawa; Chester V Oddis; Yasuo Ikeda
Journal:  Arthritis Rheum       Date:  2005-05

7.  Living-donor lobar lung transplantation experience: intermediate results.

Authors:  V A Starnes; M L Barr; R G Cohen; J A Hagen; W J Wells; M V Horn; F A Schenkel
Journal:  J Thorac Cardiovasc Surg       Date:  1996-11       Impact factor: 5.209

8.  The RIG-I-like receptor IFIH1/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody.

Authors:  Ran Nakashima; Yoshitaka Imura; Shio Kobayashi; Naoichiro Yukawa; Hajime Yoshifuji; Takaki Nojima; Daisuke Kawabata; Koichiro Ohmura; Takashi Usui; Takao Fujii; Katsuya Okawa; Tsuneyo Mimori
Journal:  Rheumatology (Oxford)       Date:  2009-12-16       Impact factor: 7.580

Review 9.  Lung transplantation in patients with scleroderma: case series, review of the literature, and criteria for transplantation.

Authors:  David Shitrit; Anat Amital; Nir Peled; Yael Raviv; Benjamin Medalion; Milton Saute; Mordechai R Kramer
Journal:  Clin Transplant       Date:  2009-02-04       Impact factor: 2.863

  9 in total
  3 in total

Review 1.  Clinical spectrum and therapeutics in Canadian patients with anti-melanoma differentiation-associated gene 5 (MDA5)-positive dermatomyositis: a case-based review.

Authors:  Kun Huang; Ophir Vinik; Kam Shojania; James Yeung; Rachel Shupak; Michael Nimmo; J Antonio Avina-Zubieta
Journal:  Rheumatol Int       Date:  2019-08-02       Impact factor: 2.631

Review 2.  A Japanese-American female with rapidly progressive interstitial lung disease associated with clinically amyopathic dermatomyositis.

Authors:  Toshinori Takada; Katsuaki Asakawa; Roberto Barrios
Journal:  Clin Rheumatol       Date:  2020-07-16       Impact factor: 2.980

3.  Interstitial Lung Disease-Complicated Anti-MDA5 Antibody in Clinically Amyopathic Dermatomyositis Patients: Report of Two Cases With Distinct Clinical Features.

Authors:  Laurence Pacot; Jacques Pouchot; Nicolas De Prost; Marie Senant; Eric Tartour; Françoise Le Pimpec-Barthes; Dominique Israel-Biet; Marie-Agnes Dragon-Durey
Journal:  Front Med (Lausanne)       Date:  2020-03-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.